AI assistant
Fulgent Genetics, Inc. — Director's Dealing 2019
Mar 6, 2019
32553_dirs_2019-03-06_94c8c48d-67da-4eaf-ac30-62fc67e88fd0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-03-05
Reporting Person: KIM PAUL (CFO and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-05 | Common Stock | S | 1165 | $4.67 | Disposed | 400015 | Direct |
Footnotes
F1: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016. The sales were effected in multiple transactions, all at a price of $4.67 per share. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares in each such transaction.